PhenUtest: Rapid diagnostic kit for antimicrobial susceptibility detection in Urinary tract infections (UTIs)
PhenUtest: Rapid diagnostic kit for antimicrobial susceptibility detection in Urinary tract infections (UTIs)
批准号:
10004417
负责人:
金额:
$32.79万
依托单位:
依托单位国家:
英国
项目类别:
Study
财政年份:
2021
资助国家:
英国
项目状态:
已结题
起止时间:
2021 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Every year, over 100 million people are diagnosed with Urinary Tract Infections (UTIs). 1 in 2 women encounters it at some point in their life, making it a major problem worldwide. UTIs are the main reason for 22.7% of the UK's community antibiotic prescriptions (source: NHS England). Mis-prescribing of antibiotics, especially in urinary tract infections, leads to antimicrobial resistance (AMR). Annually, more than 50,000 people die from antimicrobial-resistant infections in Europe and the US. By 2050, AMR is estimated to cost the global economy $100 trillion (O'Neill '14). In the UK alone, hospital-acquired UTIs amount to a cost of over £400M/year (Source: Unplanned Admissions Consensus Committee -- 2016 Updated Guide).The current UTI testing procedure involves the samples being sent to a centralized pathological lab, and it takes some 48-72 hours for the results to come back. The results include a description of the specific antibiotics that the patient should be prescribed. You as a patient, initially receive the first line of antibiotics, which is often wrong. As highlighted by NHS England in the Horizon report (Horizon Scan Report 0045, 2016) there is a serious lack of reliable, fast and cheap UTI diagnostic tests.PhenUtest brings a state-of-art technology, enabling a 30-minute (sample to diagnosis) antimicrobial susceptibility test for UTI-suspected samples which ensures that the patient gets the correct antibiotic at their first GP visit. These tests will be performed in a benchtop instrument in a primary care setting. This instrument will be highly precise, fast, cheap and easy to operate. This will reduce the risk of hospital admissions due to wrong antibiotic prescriptions.Our technology will provide an in-house rapid, accurate and cost-effective way to diagnose UTIs in the first GP visit. This will not only save health services like the NHS millions of pounds but will also reduce the growth of antibiotic resistance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Research on the Rapid Growth Mechanism of KDP Crystal
-
批准号:10774081
-
项目类别:面上项目
-
资助金额:45.0万元
-
批准年份:2007
-
负责人:滕冰
-
依托单位: